Concourse Financial Group Securities, Inc. Novartis Ag Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1,085 shares of NVS stock, worth $113,143. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,085

Previous 1,216 10.77%

Holding current value

$113,143

Previous $129,000 3.88%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$106.13 - $120.89 $13,903 - $15,836	-131 Reduced 10.77%	1,085 $124,000
Q2 2024 Jul 23, 2024	SELL	$92.57 - $107.37 $193,563 - $224,510	-2,091 Reduced 63.23%	1,216 $129,000
Q1 2024 Apr 30, 2024	SELL	$95.27 - $108.47 $1,714 - $1,952	-18 Reduced 0.54%	3,307 $319,000
Q4 2023 Feb 07, 2024	SELL	$92.27 - $101.54 $42,351 - $46,606	-459 Reduced 12.13%	3,325 $335,000
Q3 2023 Oct 25, 2023	SELL	$94.73 - $105.13 $6,536 - $7,253	-69 Reduced 1.79%	3,784 $385,000
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $222,140 - $251,888	-2,401 Reduced 38.39%	3,853 $388,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $3,441 - $3,990	-43 Reduced 0.68%	6,254 $575,000
Q4 2022 Jan 30, 2023	SELL	$75.55 - $92.52 $35,432 - $43,391	-469 Reduced 6.93%	6,297 $0
Q3 2022 Nov 15, 2022	SELL	$74.61 - $87.26 $28,127 - $32,897	-377 Reduced 5.28%	6,766 $514,000
Q2 2022 Aug 09, 2022	BUY	$80.52 - $93.75 $34,704 - $40,406	431 Added 6.42%	7,143 $604,000
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $417,693 - $472,492	-5,214 Reduced 43.72%	6,712 $589,000
Q4 2021 Feb 07, 2022	BUY	$79.7 - $88.13 $116,202 - $128,493	1,458 Added 13.93%	11,926 $1.04 Million
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $140,661 - $163,640	1,720 Added 19.66%	10,468 $856,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $120,785 - $133,410	1,417 Added 19.33%	8,748 $798,000
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $11,857 - $13,982	-142 Reduced 1.9%	7,331 $627,000
Q4 2020 Feb 02, 2021	BUY	$78.07 - $94.43 $257,240 - $311,146	3,295 Added 78.87%	7,473 $706,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $199,353 - $220,857	2,427 Added 138.61%	4,178 $363,000
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $8,254 - $9,292	-102 Reduced 5.5%	1,751 $153,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $9,045 - $12,673	128 Added 7.42%	1,853 $153,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $98,773 - $111,678	1,171 Added 211.37%	1,725 $163,000
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $151,063 - $166,463	-1,766 Reduced 76.12%	554 $48,000
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $2,714 - $3,340	-36 Reduced 1.53%	2,320 $212,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $68,239 - $78,051	906 Added 62.48%	2,356 $226,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $60,916 - $67,830	827 Added 132.74%	1,450 $124,000
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $41,703 - $48,238	623 New	623 $54,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Novartis Ag Transaction History